Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Medical Oncology-2018

About Conference

ConferenceSeries Ltd invites all the participants from all over the world to attend  International Conference on "Haematology and Oncology” during May28- 30, 2018 in Osaka, Japan. The conference will be organized around the theme “An Eye towards “Haematology and Oncology”

Why to attend?

With members from around the world focused on learning about Hematology and Blood Disorders; this is your best opportunity to reach the largest assemblage of participants from the Cancer community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Haematology & in oncology, treatment and surgery involved are hallmarks of this conference.

Haematology and Oncology 2018 welcomes immunologists, pathologists, haematologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it.

Target Audience:

  •  Business Entrepreneurs Public
  •  Health Professionals
  •  Drug Manufacturing Companies
  •  Radiation Therapist
  •  Oncology Societies
  •  Clinical Researchers
  •  Leading world Doctors
  •  Surgical and Medical Hematologist
  • Young Researchers
  • Students & Delegates

Conference highlights

  • Haematology
  • Haematologic-Oncology
  • Blood Disorders and Blood oncology
  • Leukemia Immunology
  • Haemato Immunology &Stem Cell Research
  • Haematological malignancies
  • Biomarkers
  • Advances in Bone Marrow Transplantation and surgery
  • Oncology
  • Cancer Epidemiology
  •  Gynecologic oncology

 

     

Market Analysis

Summary

Hematology is the branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to blood. It involves treating diseases that affect the production of blood and its components such as blood cells, haemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. A blood cell disorder is a condition in which there’s a problem with your red blood cells, white blood cells, or the smaller, circulating cells called platelets, which are critical for clot formation. All three cell types form in the bone marrow, which is the soft tissue inside your bones.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Hematology and Oncology 2018, where you will be sure to have a meaningful experience with scholars from around the world.

Importance & scope

Hematology & oncology Conference- Osaka, japan is the best platform for the experts, doctors, researchers, students and business delegates with its well organized scientific program covering every minute detail about Hematology and blood diseases, from the basic causes behind blood diseases to the latest trends in diagnostic and treatment of blood diseases. This international event is an effort to find a weapon against chronic disorders like blood cancer, Sickle cell anaemia, haemophilia, lymphoma and myeloma and to discuss the role of Immunoglobulin in blood, antibody and antigen reactions, the red blood cell and the immunological properties of blood which gives a better insight about the associated causes and disease portfolio.

ConferenceSeries Ltd welcomes all the haematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed Blood Disorders 2018. Advanced Diagnostic and therapeutic equipment  along with the novel drugs for  the  blood diseases are an integral part of the Hematology research, hence it will be an excellent amalgamation of academia and industry as it involves  every aspects of empirical and conceptual thinking  in exploring new dimensions in this field.  It is open to all types of research methodologies both from academia and industry.

Why Osaka, Japan?  

Japan is considered as an important centre for higher education and harbours, healthcare, well reputed and prestigious colleges and Universities. It can be considered as a suitable medium for the relocation of valuable knowledge about research and novel advancements worldwide. The conferences taking part here would promote a variety of scientific ideas among contenders belonging to diverse areas of science and technology. Japanese outcomes for high level medical treatment are generally competitive with that of the US. A comparison of two reports in the New England Journal of Medicine  suggest that outcomes for gastro-oesophageal cancer is better in Japan than the US in both patients treated with surgery alone and surgery followed by chemotherapy. Japan excels in the five-year survival rates of colon cancer, lung cancer, pancreatic cancer and liver cancer based on the comparison of a report by the American Association of Oncology and another report by the Japan Foundation for the Promotion of Cancer research. The same comparison shows that the US excels in the five-year survival of rectal cancer, breast cancer, prostate cancer and malignant lymphoma. Surgical outcomes tend to be better in Japan for most cancers while overall survival tend to be longer in the US due to the more aggressive use of chemotherapy in late stage cancers. A comparison of the data from United States Renal Data System (USRDS) 2009 and Japan Reno logy Society 2009 shows that the annual mortality of patients undergoing dialysis in Japan is 13% compared to 22.4% in the US. Five-year survival of patients under dialysis is 59.9% in Japan and 38% in the US.

   Cancer Universities in Japan

  • National Cancer Centre Hospital
  • Aichi Cancer Centre
  • Kyoto Prefectural University of Medicine
  • Tohoku University
  • Kyoto University
  • Chiba University
  • Osaka University

Universities Worldwide

  •  University of Oxford
  • University of Cambridge
  • UCL London's Global University
  • Stanford University
  • Western University
  • University of Nottingham
  • University of Bologna
  • University of Athens
  • University of Chicago
  • University of Washington
  • University of Rochester
  • The University of Melbourne
  • University of Glasgow
  • Fudan University
  • Stanford University
  • University of Minnesota
  • University of Albert
  • University of Nebraska
  • University of Iowa Carver
  • University of Pennsylvania
  • South-western University
  • University of Pittsburgh
  • University of Helsinki
  • University of Penn Medicine

  Universities in Asia

  • Osaka University
  • Tsinghua University
  • Fudan University
  • Taipei Medical University
  • KAIST - Korea Advanced Institute of Science and Technology
  • Yonsei University
  • Shanghai Jiao Tong University
  • Nanyang Technological University (NTU)
  • Chulalongkorn Universit
  • Tohoku University
  • Tokyo Medical and Dental University
  • Kyushu University
  • Nagoya University
  • Hokkaido University
  • Sungkyunkwan Universit
  •  Indian Institute of Science
  • University Kebangsaan Malaysia (UKM)
  • University Saints Malaysia (USM)
  • Beijing University of Chinese Medicine
  • National Tsing Hua University

        

                 Ratio of universities worldwide (fig 1)

Associations in Japan 

  • The Japanese Breast Cancer Society
  • The Japanese Cancer Association
  • Japan Society of Clinical Oncology
  • Japanese Gastric Cancer Association
  • The Japanese Society of Hematology
  • The Japan Lung Cancer Society
  •  Japanese Society of Medical Oncology (JSMO)
  • The Japanese Society of Paediatric Hematology/Oncology
  • Japan Primary Care Association

 Associations Worldwide

  • Life South Community Blood Centre
  • World congress of the International society of Hematology
  • International society of Hematology
  • World federation of Haemophilia
  • European Hematology Associations
  • Malaysian society of Hematology
  • Armenian associations of Hematology & Oncology
  • Japanese society of Hematology
  • Japan Primary Care Association

  Association in Asia Pacific

  • The Asia-Pacific Urogynecology Association
  • The Asia-Pacific Cancer Society Training
  • Asian Cancer Foundation India
  • The Max Foundation
  • Childhood Cancer International Netherlands
  • The Asia Pacific Prostate Society

 

                        Ratio of Associations in worldwide (fig 2)

Pharmaceutics company in Japan

  • Takeda
  • Otsuka
  • Meiji   
  • Daiichi Sankyo
  • Astellas
  • Teijin
  • Chugai  
  •  Mitsubishi Tanabe    
  •  Kyowa Hakko Kirin  
  • Taisho
  • Shionogi
  •  Ono        
  •  Hisamitsu
  • Santel
  • Kyorin
  • Nichi-Iko
  • Mochida
  •  Kaken   
  •  Sawai    
  •  Kissei    
  •  Towa     
  •  Zeria      
  •  Torii              
  •  takedaDaito

     Cancer hospitals in Japan

  • St Luke's International Hospital
  • National Cancer Centre Hospital, Tokyo ,Japan
  • Japan Red Cross Medical Centre
  • Shizuoka Cancer Centre
  • Chiba university hospital

     Cancer hospitals worldwide

  •  Leiden University Medical Centre
  • Royal Cancer Hospital
  • King’s College Hospital
  • Clatter bridge Centre for Oncology
  • Northampton General Hospital
  • Cambridge University Hospitals
  • University Hospital Southampton
  • Central Manchester University Hospitals

Sessions/ Tracks

Track 1: Hematology

Erythrocytes are also called as red platelets which convey oxygen to the body and gather carbon dioxide from the body by the use of hemoglobin and its life expectancy of 120 days. At the edge the leucocytes helps in ensuring the healthy cells in light of the fact that the W.B.C (leucocytes) go about as the defending cells in protecting  the immune system from the outside cells. Formation of blood cellular componrents are called as Hematopoiesis and all the cellular blood segments are gotten from hematopoiesis stem cells in a healthy individual almost 1011–1012 fresh blood cells are produced these assistance in steady peripheral circulation. In the event that there is an increments of R.B.C in the body these causes polycythemia these can be measured through haematocrit level.

Related Conferences:  Haematology Conference | Leukemia Conference | CME Conference | Oncology Conferences |International Events| Osaka| Japan| Asia Pacific| ConferenceSeries

12th Dutch Haematology Congress January 24- 26,2018 Arnhem , Netherland; 10th Annual T-cell Lymphoma Forum February 1-3, 2018 Hilton La Jolla Torrey Pines US; 38th Annual Conference on Clinical Hematology & Oncology  February 17-20,2018 Hyatt Regency La Jolla at Aventine US; HEMONC TODAY New York March 8-10, 2018 New York; San Antonio Breast Cancer Symposium December 4-8, 2018 San Antonio, TX; Global Summit on Oncology & Cancer March 14-16, 2018 Singapore;12th World Haematologists Congress March 15-16, 2018 London, UK; Global Meeting on Clinical Oncology and Radiology April 16-17, 2018 Dubai, UAE 11th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany ;22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

Track 2: Hematologic-oncology

Hematologic Oncology is the branch of medicine study about the diagnosis ,prevention, treatment, and avoidance of disease identified with blood. Hematology incorporates the study of etiologist includes treating disease that influence the production of blood and its parts, for example, platelets, hemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the component of coagulation. The research facility work that goes into the study of blood is much of the time performed by a medical technologist or therapeutic lab researcher. Hematologists also conduct study in oncology and work with oncologists, individuals who may specialize just in that field rather than both-the therapeutic treatment of tumor. There are different disorders that people are influenced by hematology. A couple of these different type of blood conditions that are looked at incorporate anaemia, hemophilia, general blood clots, bleeding disorders, and so forth. With respect to related blood diseases, for example, leukemia, myeloma, and lymphoma, these are more serious cases that should be analysed.

Related Conferences Haematology Conference | Leukemia Conference | CME Conference | Oncology Conferences |International Events| Osaka| Japan| Asia Pacific| ConferenceSeries

12th Dutch Haematology Congress January 24- 26,2018 Arnhem , Netherland; 10th Annual T-cell Lymphoma Forum February 1-3, 2018 Hilton La Jolla Torrey Pines US; 38th Annual Conference on Clinical Hematology & Oncology  February 17-20,2018 Hyatt Regency La Jolla at Aventine US; HEMONC TODAY New York March 8-10, 2018 New York; San Antonio Breast Cancer Symposium December 4-8, 2018 San Antonio, TX; Global Summit on Oncology & Cancer March 14-16, 2018 Singapore;12th World Haematologists Congress March 15-16, 2018 London, UK; Global Meeting on Clinical Oncology and Radiology April 16-17, 2018 Dubai, UAE 11th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany ;22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

Track 3: Blood Disorders and Blood oncology

Iron deficiency is the most well-known sort of blood issue we treat. Patients with anaemia have an insufficiency of oxygen-rich red platelets or their red platelets don't work appropriately. A low level of hemoglobin, the iron-rich protein that conveys the oxygen in red platelets, flags the condition. Anaemia can be constant, or a brief condition caused by other medical problems, including growth treatment, hepatitis C, and HIV/AIDS. Anemia every now and again stays undiscovered in light of the fact that it is a fundamental state of other medical problems, including growth, cardiovascular malady, diabetes, HIV/AIDS, fiery entrail sickness, unending kidney infection, and rheumatoid joint pain. Hemophilia is a rare typicall inherited blood disorder, commonly acquired blood issue in which the blood does not appropriately clump and causeintemprate dying, which can make harm organs, joints, and tissues. Patient may experience the ill effects of the site of damage or from inward dying. Coagulating Disorders Hematologists likewise treat conditions identified with the proteins that trigger draining and thickening, including thrombosis (thickening) and hemostasis (dying). Thrombosis refers to the formation of abnormal blood clots that become embedded in a major vein or artery, blocking blood circulation. Blood clots can cause pain, swelling, or warmth in the affected area, and can be life-threatening. Hemostasis is the process of controlling bleeding. Blood Cancers Cancerous blood conditions include leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma.

Related Conferences Haematology Conference | Leukemia Conference | CME Conference | Oncology Conferences |International Events| Osaka| Japan| Asia Pacific| ConferenceSeries

12th Dutch Haematology Congress January 24- 26,2018 Arnhem , Netherland; 10th Annual T-cell Lymphoma Forum February 1-3, 2018 Hilton La Jolla Torrey Pines US; 38th Annual Conference on Clinical Hematology & Oncology  February 17-20,2018 Hyatt Regency La Jolla at Aventine US; HEMONC TODAY New York March 8-10, 2018 New York; San Antonio Breast Cancer Symposium December 4-8, 2018 San Antonio, TX; Global Summit on Oncology & Cancer March 14-16, 2018 Singapore;12th World Haematologists Congress March 15-16, 2018 London, UK; Global Meeting on Clinical Oncology and Radiology April 16-17, 2018 Dubai, UAE 11th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany ;22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

Track 4: Leukemia immunology

Cancer  immunology is a branch of immunology that studies interaction between the immune system and cancer cells (likewise called tumors or malignancies). It is a developing field of research that plans to find inovative malignancy immunotherapies to treat and retard movement of diseaes. The immune  system  reaction, including the acknowledgment of disease particular antigens, is specifically compelling in the field as knowledge gained drives the development of targeted therapy (such as new vaccines and antibody therapies) and tumor marker-based diagnostic tests.

Related Conferences Haematology Conference | Leukemia Conference | CME Conference | Oncology Conferences |International Events| Osaka| Japan| Asia Pacific| ConferenceSeries

12th Dutch Haematology Congress January 24- 26,2018 Arnhem , Netherland; 10th Annual T-cell Lymphoma Forum February 1-3, 2018 Hilton La Jolla Torrey Pines US; 38th Annual Conference on Clinical Hematology & Oncology  February 17-20,2018 Hyatt Regency La Jolla at Aventine US; HEMONC TODAY New York March 8-10, 2018 New York; San Antonio Breast Cancer Symposium December 4-8, 2018 San Antonio, TX; Global Summit on Oncology & Cancer March 14-16, 2018 Singapore;12th World Haematologists Congress March 15-16, 2018 London, UK; Global Meeting on Clinical Oncology and Radiology April 16-17, 2018 Dubai, UAE 11th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany ;22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

Track 5: Hemato- Immunology & Stem Cell Research

Blood group are of ABO sort and however at introduce the Rh blood gathering of 50 very much characterized antigens in which 5 are more vital they are D,C,c,E and e and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in anticipation of erythroblast fetalis lacking of Rh antigen it characterized as negative and existences of Rh antigen in blood prompts positive these prompts rh inconsistency. The prevention treatment of illnesses identified with the blood is called as the Hematology. The haematologists conduct a work at cancer to. The disorder of immune system leading to the hypersensitivity is called as Clinical Immunology and the abnormal development of a disease are known as Inflammation and the emerge of an abnormal immune reaction to the body or an immune suppression are known as Auto immune disorder. The undifferentiated cell treatment is utilized to treat or keep an illness or a condition for the mostly Bone marrow undifferentiated cell treatment is seen and as of late umbilical cord treatment Stem cell transplantation methodologies remains an unsafe system with many possible confusions; it is saved for patients with life-threatening sicknesses.

Related Conferences Haematology Conference | Leukemia Conference | CME Conference | Oncology Conferences |International Events| Osaka| Japan| Asia Pacific| ConferenceSeries

12th Dutch Haematology Congress January 24- 26,2018 Arnhem , Netherland; 10th Annual T-cell Lymphoma Forum February 1-3, 2018 Hilton La Jolla Torrey Pines US; 38th Annual Conference on Clinical Hematology & Oncology  February 17-20,2018 Hyatt Regency La Jolla at Aventine US; HEMONC TODAY New York March 8-10, 2018 New York; San Antonio Breast Cancer Symposium December 4-8, 2018 San Antonio, TX; Global Summit on Oncology & Cancer March 14-16, 2018 Singapore;12th World Haematologists Congress March 15-16, 2018 London, UK; Global Meeting on Clinical Oncology and Radiology April 16-17, 2018 Dubai, UAE 11th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany ;22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

Track 6: Cancer and Alternative Medicine

Ayurvedic drug is an old Indian system of medication which started around 5,000 years prior. It is not only one treatment. It is a method for diagnosing disease and utilizing an extensive variety of medications and strategies. Home grown medication utilizes plants, or blends of plant mixture, to treat disease and promote health. It intends to restore your body's capacity to secure, manage and heal itself. It is an entire body approach, so look   at your physical, mental and emotional well-being. It is now and again called phytomedicine, phytotherapy or natural pharmaceutical. Naturopathic specialists (NDs) trust that cancer emerges from an imbalance that causes a systemic breakdown inside the body. Homeopathy depends on the hypothesis of treating like with like. So to treat a sickness a homeopathic specialist (homeopath) utilizes minor dose of a substance that in large dosages would actually cause the symptom of the illness.

Related Conferences Haematology Conference | Leukemia Conference | CME Conference | Oncology Conferences |International Events| Osaka| Japan| Asia Pacific| ConferenceSeries

12th Dutch Haematology Congress January 24- 26,2018 Arnhem , Netherland; 10th Annual T-cell Lymphoma Forum February 1-3, 2018 Hilton La Jolla Torrey Pines US; 38th Annual Conference on Clinical Hematology & Oncology  February 17-20,2018 Hyatt Regency La Jolla at Aventine US; HEMONC TODAY New York March 8-10, 2018 New York; San Antonio Breast Cancer Symposium December 4-8, 2018 San Antonio, TX; Global Summit on Oncology & Cancer March 14-16, 2018 Singapore;12th World Haematologists Congress March 15-16, 2018 London, UK; Global Meeting on Clinical Oncology and Radiology April 16-17, 2018 Dubai, UAE 11th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany ;22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

Track 7: Haematological malignancies

Hematologic malignancies are types of cancer that starts in the cells of blood-shaping   tissue, for example, the bone marrow, or in the cells of the immune system. Cases of hematologic disease are intense and endless Leukemia, lymphomas, and numerous myeloma and myelodysplastic disorders. Myeloproliferative neoplasms, or MPNs, are hematologic  growths that arise from dangerous hematopoietic myeloid progenitor cells in the bone marrow, for example, the precursor cells of red cells, platelets and granulocytes .Included in the MPN disease spectrum are essential thrombocythemia, polycythemia Vera and myelofibrosis . This logical session will concentrate on a wide range of normal or uncommon blood tumours, for example, intense promyelocytic Leukemia (APL) and interminable myelomonocytic Leukemia bristly cell Leukemia (HCL), expansive granular lymphocytic Leukemia (LGL), white blood cell intense lymphoblastic Leukemia (T-ALL), Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma Multiple myeloma, Childhood Leukemia  and Myelodysplastic–Myeloproliferative disease. The estimate of how the disease will go for a patient is called prognosis. There are many factors influence prognosis   that include:  the kind of cancer and where it is in the body, the phase of the cancer, the cancer grade. Grad   gives signs about how rapidly the disease is probably going to develop and spread certain traits of the tumour cells, the age and how healthy body was before cancer and how fruitful is the treatment.

Related Conferences Haematology Conference | Leukemia Conference | CME Conference | Oncology Conferences |International Events| Osaka| Japan| Asia Pacific| ConferenceSeries

12th Dutch Haematology Congress January 24- 26,2018 Arnhem , Netherland; 10th Annual T-cell Lymphoma Forum February 1-3, 2018 Hilton La Jolla Torrey Pines US; 38th Annual Conference on Clinical Hematology & Oncology  February 17-20,2018 Hyatt Regency La Jolla at Aventine US; HEMONC TODAY New York March 8-10, 2018 New York; San Antonio Breast Cancer Symposium December 4-8, 2018 San Antonio, TX; Global Summit on Oncology & Cancer March 14-16, 2018 Singapore;12th World Haematologists Congress March 15-16, 2018 London, UK; Global Meeting on Clinical Oncology and Radiology April 16-17, 2018 Dubai, UAE 11th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany ;22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

Track 8: Biomarkers

Protein Biomarkers can be used as biomarkers for early recognition of cancer particularly used for the identification of breast cancer. Diagnostic Patients with suspected pancreatic cancer will experience an underlying CT scan to decide if a suspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-respectable stage III and IV disease and a biopsy will be attempted to confirm pancreatic tumour by H&E pathological assay. The presence of cancerous cells by means of pathology is very challenging because of high quantities of non-cancerous stromal infiltrating cells and administration of chemotherapy or enrolment into a clinical trial will just initiate on definitive diagnosis of pancreatic cancer. These will see particularly stains neoplastic pancreatic cells would empower the pathologist to confidently diagnose pancreatic cancer and in this way offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 has been recognized as a highly sensitive (98%) and particular (95%) IHC marker for pancreatic cancer and CRT is looking for a partner to build up an IHC based test to distinguish BI-010 in fine needle suction biopsies from biopsy tests.

Related Conferences Haematology Conference | Leukemia Conference | CME Conference | Oncology Conferences |International Events| Osaka| Japan| Asia Pacific| ConferenceSeries

12th Dutch Haematology Congress January 24- 26,2018 Arnhem , Netherland; 10th Annual T-cell Lymphoma Forum February 1-3, 2018 Hilton La Jolla Torrey Pines US; 38th Annual Conference on Clinical Hematology & Oncology  February 17-20,2018 Hyatt Regency La Jolla at Aventine US; HEMONC TODAY New York March 8-10, 2018 New York; San Antonio Breast Cancer Symposium December 4-8, 2018 San Antonio, TX; Global Summit on Oncology & Cancer March 14-16, 2018 Singapore;12th World Haematologists Congress March 15-16, 2018 London, UK; Global Meeting on Clinical Oncology and Radiology April 16-17, 2018 Dubai, UAE 11th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany ;22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

Track 9: Advances in Bone Marrow Transplantation and surgery

Bone Marrow Transplantation: A bone marrow transplant, also called as haemopoietic stem cell transplant, replaces damaged bone marrow with healthy bone marrow cells. Bone marrow is an elastic tissue found in the empty focuses of a few bones. It contains specialist stem cell, which create the body's cell. A biopsy is a specimen of tissue taken from the body in order to examine it more intently. A doctor should prescribe a biopsy when an initial test suggests that a region of tissue in the body isn't normal. Doctors may call that region of abnormal tissue an injury, a tumour, or a mass.Topics of exchange in the scientific sessions are Bone Marrow Surgery, Stem Cell Surgery, Hematopoietic Cell Transplantations. An expanding number of   diseases may be treated effectively by allogeneic bone marrow transplantation (BMT). Initially used for the treatment of immunodeficiency where a cell arrangement or product is replaced, it has now turned out to be standard treatment for some types of Leukemia where the transplant gives the protection after deadly marrow removal. As of recent, disease, for example, thalassemia and other acquired metabolic illnesses have also been treated with by BMT. In the past the issues of BMT were for the most part worried about graft versus host disease (GVHD) in HLA-matched transplants with HLA-mismatched ones not being possible as GVHD was generally fatal. Since the advancement of methods for T cell removal the occurrence of GVHD has greatly diminished. White blood cell removal has likewise permitted HLA haploidentical mismatched graft to be performed effectively for immunodeficiency, but still there is a high graft rejection rate in Leukemia.

Related Conferences Haematology Conference | Leukemia Conference | CME Conference | Oncology Conferences |International Events| Osaka| Japan| Asia Pacific| ConferenceSeries

12th Dutch Haematology Congress January 24- 26,2018 Arnhem , Netherland; 10th Annual T-cell Lymphoma Forum February 1-3, 2018 Hilton La Jolla Torrey Pines US; 38th Annual Conference on Clinical Hematology & Oncology  February 17-20,2018 Hyatt Regency La Jolla at Aventine US; HEMONC TODAY New York March 8-10, 2018 New York; San Antonio Breast Cancer Symposium December 4-8, 2018 San Antonio, TX; Global Summit on Oncology & Cancer March 14-16, 2018 Singapore;12th World Haematologists Congress March 15-16, 2018 London, UK; Global Meeting on Clinical Oncology and Radiology April 16-17, 2018 Dubai, UAE 11th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany ;22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

Track 10 : Oncology

Oncology is the study of tumour. An oncologist is a master who treats cancer. More often than not, an oncologist manages care and treatment once he or she is determined to have cancer. A therapeutic oncologist treats cancer using chemotherapy or diverse medications, for instance, targeted therapy. A surgical oncologist removes the tumour and nearby tissue in the midst of an operation. A radiation oncologist treats cancer using radiation therapy. Oncologists may segment on the introduction of the kind of treatment given to treat the cancer. Molecular oncology is the study of science of disease and tumour cell at its molecular cell. Surgical oncology is the branch of oncology which deals with the surgery associated with oncology. Gynaecologic oncology is one which focuses on different developments of the female reproductive system.

Related Conferences Haematology Conference | Leukemia Conference | CME Conference | Oncology Conferences |International Events| Osaka| Japan| Asia Pacific| ConferenceSeries

12th Dutch Haematology Congress January 24- 26,2018 Arnhem , Netherland; 10th Annual T-cell Lymphoma Forum February 1-3, 2018 Hilton La Jolla Torrey Pines US; 38th Annual Conference on Clinical Hematology & Oncology  February 17-20,2018 Hyatt Regency La Jolla at Aventine US; HEMONC TODAY New York March 8-10, 2018 New York; San Antonio Breast Cancer Symposium December 4-8, 2018 San Antonio, TX; Global Summit on Oncology & Cancer March 14-16, 2018 Singapore;12th World Haematologists Congress March 15-16, 2018 London, UK; Global Meeting on Clinical Oncology and Radiology April 16-17, 2018 Dubai, UAE 11th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany ;22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

Track 11: Cancer Epidemiology

The study of disease transmission of tumour is the investigation   of the components affecting development, as a way to deal with finds possible examples and causes. Epidemiology is the investigation of the circulation and determinants of wellbeing related states or events in demonstrated masses, and the use of this audit to control of well-being issues. The most basic risk variable is age. Other hazard components fuse tobacco smoking, alcohol drinking and physical dormancy.

Related Conferences Haematology Conference | Leukemia Conference | CME Conference | Oncology Conferences |International Events| Osaka| Japan| Asia Pacific| ConferenceSeries

12th Dutch Haematology Congress January 24- 26,2018 Arnhem , Netherland; 10th Annual T-cell Lymphoma Forum February 1-3, 2018 Hilton La Jolla Torrey Pines US; 38th Annual Conference on Clinical Hematology & Oncology  February 17-20,2018 Hyatt Regency La Jolla at Aventine US; HEMONC TODAY New York March 8-10, 2018 New York; San Antonio Breast Cancer Symposium December 4-8, 2018 San Antonio, TX; Global Summit on Oncology & Cancer March 14-16, 2018 Singapore;12th World Haematologists Congress March 15-16, 2018 London, UK; Global Meeting on Clinical Oncology and Radiology April 16-17, 2018 Dubai, UAE 11th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany ;22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

Track 12: Gynaecologic oncology

Gynaecologic is a specific field of medication that spotlights on developments of the female conceptive structure, including ovarian cancer, uterine tumour, vaginal disease, cervical cancer, and vulvar disease. As specialists, they have wide get ready in the conclusion and treatment of these tumours. A gynaecologic oncologist is a specialist who represents impressive expert in diagnosing and treating disease that are arranged on a woman's conceptive organs.

Related Conferences Haematology Conference | Leukemia Conference | CME Conference | Oncology Conferences |International Events| Osaka| Japan| Asia Pacific| ConferenceSeries

12th Dutch Haematology Congress January 24- 26,2018 Arnhem , Netherland; 10th Annual T-cell Lymphoma Forum February 1-3, 2018 Hilton La Jolla Torrey Pines US; 38th Annual Conference on Clinical Hematology & Oncology  February 17-20,2018 Hyatt Regency La Jolla at Aventine US; HEMONC TODAY New York March 8-10, 2018 New York; San Antonio Breast Cancer Symposium December 4-8, 2018 San Antonio, TX; Global Summit on Oncology & Cancer March 14-16, 2018 Singapore;12th World Haematologists Congress March 15-16, 2018 London, UK; Global Meeting on Clinical Oncology and Radiology April 16-17, 2018 Dubai, UAE 11th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany ;22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

 Track 13 : Oncology nursing

An oncology nurse is a selected nurture who takes care of and shows patients who have tumour. Oncology specialists work in a multi-disciplinary gathering, in a combination of settings, from the inpatient ward, where it counts marrow transplant unit, through to the group. They may work with a variety of patients, from children to the elderly, from outpatients through to palliative care.

Related Conferences Haematology Conference | Leukemia Conference | CME Conference | Oncology Conferences |International Events| Osaka| Japan| Asia Pacific| ConferenceSeries

12th Dutch Haematology Congress January 24- 26,2018 Arnhem , Netherland; 10th Annual T-cell Lymphoma Forum February 1-3, 2018 Hilton La Jolla Torrey Pines US; 38th Annual Conference on Clinical Hematology & Oncology  February 17-20,2018 Hyatt Regency La Jolla at Aventine US; HEMONC TODAY New York March 8-10, 2018 New York; San Antonio Breast Cancer Symposium December 4-8, 2018 San Antonio, TX; Global Summit on Oncology & Cancer March 14-16, 2018 Singapore;12th World Haematologists Congress March 15-16, 2018 London, UK; Global Meeting on Clinical Oncology and Radiology April 16-17, 2018 Dubai, UAE 11th International Conference on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany ;22nd Global Annual Oncologists Meeting May 24-25, 2018 Osaka, Japan

To Collaborate Scientific Professionals around the World

Conference Date May 28-30, 2018

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Cancer Science & Therapy Chemotherapy: Open Access Journal of Integrative Oncology Advances in Oncology Research and Treatments

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by